| Upcoming events on ASTEX PHARMACEUTICALS INC |
|
| 07/25/13 | | Q2 2013 Earnings Release (Projected) |
| 10/28/13 | | Q3 2013 Earnings Release (Projected) |
| 03/03/14 | | Q4 2013 Earnings Release (Projected) |
| 04/28/14 | | Q1 2014 Earnings Release (Projected) |
|
| Past events on ASTEX PHARMACEUTICALS INC |
|
| 05/20/13 | 03:30pm | | UBS Global Healthcare Conference |
| 04/30/13 | 08:00am | | Needham Health Care Conference |
| 04/29/13 | 04:30pm | | Q1 2013 Earnings Call |
| 04/29/13 | | Q1 2013 Earnings Release |
|
|
|
| Annual results | 2010 | 2011 | 2012 | 2013 (e) | 2014 (e) |
Sales
Million $ |
Released
Forecast
Spread | 53,0
51,9
2,1% | 66,9
66,5
0,62% | 83,2
82,0
1,4% |
56,1
|
25,9
|
Operating income (EBITDA)
Million $ |
Released
Forecast
Spread | 17,2
15,2
13% | 8,31
10,1
-18% | 2,48
10,7
-77% |
-22,0
|
-61,5
|
Operating profit (EBIT)
Million $ |
Released
Forecast
Spread | 15,9
11,9
33% |
-6,88
| -7,05
-8,70
19% |
-36,5
|
-77,8
|
Pre-Tax Profit (EBT)
Million $ |
Released
Forecast
Spread |
| 2,25
|
|
|
|
Net income
Million $ |
Released
Forecast
Spread | 16,3
12,4
31% | 5,54
3,91
42% |
|
-30,3
|
-67,2
|
EPS
$ |
Released
Forecast
Spread | 0,27
0,20
33% | 0,07
0,09
-20% |
|
-0,32
|
-0,72
| | Announcement Date | 02/28/2011 | 03/05/2012 | 02/25/2013 | | |
|
| Quarterly / Semiannualy publications |
|
| Quarterly results | Q2
2012 | Q4
2012 | Q1
2013 | Q2
2013 (e) | Q3
2013 (e) |
Sales
Million $ |
Released
Forecast
Spread |
| 24,1
22,9
5,1% | 22,1
18,5
20% |
15,7
|
12,9
|
Operating income (EBITDA)
|
Released
Forecast
Spread |
|
|
|
|
|
Operating profit (EBIT)
Million $ |
Released
Forecast
Spread |
-8,27
| 1,28
-0,40
421% | -1,82
-4,97
63% |
-7,17
|
-10,2
|
Pre-Tax Profit (EBT)
|
Released
Forecast
Spread |
|
|
|
|
|
Net income
|
Released
Forecast
Spread |
|
|
|
|
|
EPS
|
Released
Forecast
Spread |
|
|
|
|
| | Announcement Date | | 02/25/2013 | 04/29/2013 | | |
|
© 2013 Thomson Reuters
© 2013 Factset
|
|
| Net sales - Rate of surprise |
|
|
| Operating profit - Rate of surprise |
|
|
|
Previous year
